Live Breaking News & Updates on Arnon Kater

Stay updated with breaking news from Arnon kater. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Venetoclax Plus Rituximab Provides Long-Term Survival Benefit in Relapsed/Refractory CLL

Treatment with fixed-duration venetoclax plus rituximab continued to show superior survival benefit vs bendamustine and rituximab in patients with relapsed/refractory chronic lymphocytic leukemia, according to 7-year follow up data from the phase 3 MURANO trial. ....

Noord Holland , Arnon Kater , Arnonp Kater , Amsterdam University Medical Centers ,

Venetoclax Plus Rituximab Provides Long-Term Survival Benefit in R/R CLL

Treatment with fixed-duration venetoclax plus rituximab continued to show superior survival benefit vs bendamustine and rituximab in patients with relapsed/refractory chronic lymphocytic leukemia, according to 7-year follow up from the phase III MURANO trial. ....

Noord Holland , Arnonp Kater , Arnon Kater , Amsterdam University Medical Centers ,

LAVA Therapeutics Announces Updated Data from the Phase

Poster presentation to include initial data from subcutaneous administration and updates on intravenous dosing-cohorts. ....

United States , New Orleans , Noord Holland , Arnon Kater , Arnonp Kater , American Society Of Hematology , Amsterdam University Medical Center , American Society , Annual Meeting , Stephen Hurly , Novel Bispecific Gamma Deltat Cell Engager , Early Clinical , Early Phase , Investigational Therapies , Amsterdam University Medical , Nasdaq Lvtx , Lava Therapeuticsnv ,

LAVA Therapeutics Provides Business Update and Reports Third Quarter Financial Results

LAVA Therapeutics Provides Business Update and Reports Third Quarter Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Noord Holland , Arnon Kater , Fred Powell , Society For Immunotherapy , American Society Of Hematology , Amsterdam University Medical Center , Stage Gammabody Pipeline Development , Stephen Hurly , Annual Meeting , New Orleans , Novel Bispecific Gamma Deltat Cell Engager , Early Clinical Data , Early Phase , Investigational Therapies , Janssen Biotech , Consolidated Interim Statements , Comprehensive Profit ,

LAVA Therapeutics Provides Business Update and Reports Second Quarter Financial Results

13.09.2022 - Initial Phase 1/2a clinical findings for LAVA-051 in patients with chronic lymphocytic leukemia and multiple myeloma patients demonstrated encouraging anti-tumor activity and safety profile; on track to report additional clinical data in fourth . ....

United States , Noord Holland , Benjamin Winograd , Arnon Kater , Stagegammabodypipeline Development , Amsterdam University Medical Center , Drug Administration , Recent Pipeline , Immaterial Misstatements , Janssen Biotech , Consolidated Interim Statements ,